Evidence map›Paper›PMID 35482115›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2022

Correction to: Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[

Sofia C Vaz, Judit A Adam, Roberto C Delgado Bolton, Pierre Vera, Wouter van Elmpt, Ken Herrmann, Rodney J Hicks, Yolande Lievens, Andrea Santos, Heiko Schöder and 4 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Sofia C VazNuclear Medicine Radiopharmacology, Champalimaud Centre for the Unkown, Champalimaud Foundation, Lisbon, Portugal.
Judit A AdamDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Roberto C Delgado BoltonDepartment of Diagnostic Imaging (Radiology) and Nuclear Medicine, University Hospital San Pedro and Centre for Biomedical Research of La Rioja (CIBIR), Logroño (La Rioja), Spain.
Pierre VeraHenri Becquerel Cancer Center, QuantIF-LITIS EA 4108, Université de Rouen, Rouen, France.
Wouter van ElmptDepartment of Radiation Oncology (MAASTRO), GROW - School for Oncology, Maastricht University Medical Centre, Maastricht, The Netherlands.
Ken HerrmannDepartment of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK) University Hospital Essen, Essen, Germany. ken.herrmann@uk-essen.de.
Rodney J HicksThe Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.
Yolande LievensRadiation Oncology Department, Ghent University Hospital and Ghent University, Ghent, Belgium.
Andrea SantosNuclear Medicine Department, CUF Descobertas Hospital, Lisbon, Portugal.
Heiko SchöderMolecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, USA.
Bernard DubrayDepartment of Radiotherapy and Medical Physics, Centre Henri Becquerel, Rouen, France.
Dimitris VisvikisLaTIM, INSERM, UMR1101, Brest, France.
Esther G C TroostDepartment of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Lioe-Fee de Geus-OeiDepartment of Radiology, Leiden University Medical Center, Leiden, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35482115
PMCPMC9250452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.